XM does not provide services to residents of the United States of America.

U.S. STOCKS Estee Lauder, Enphase, GE Vernova



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BUZZ-U.S. STOCKS ON THE MOVE-Estee Lauder, Enphase, GE Vernova</title></head><body>

Eikon search string for individual stock moves: STXBZ

The Day Ahead newsletter: https://refini.tv/3LI4BU7

The Morning News Call newsletter: https://refini.tv/3dKUyB8

Wall Street futures fell on Wednesday, with those tracking the tech-heavy Nasdaq recording the steepest losses after weak quarterly earnings from Tesla and Alphabet, as investors questioned the dominance of Big Tech and euphoria around AI. .N


At 7:31 ET, Dow e-minis 1YMc1 were down 0.34% at 40,476. S&P 500 e-minis ESc1 were down 0.65% at 5,562.75, while Nasdaq 100 e-minis NQc1 were down 1.02% at 19,722.5.

The top three NYSE percentage gainers premarket .PRPG.NQ:
** Schneider National SNDR.N, up 6.1%
** Tenet Healthcare THC.N, up 5.1%
** KORE Group Holdings KORE.N, up 4.7%

The top three NYSE percentage losers premarket .PRPL.NQ:
** ATI Physical Therapy ATIP.N, down 25.8%
** Terran Orbital LLAP.N, down 13.5%
** SFL SFL.N, down 9.4%

The top three Nasdaq percentage gainers premarket .PRPG.O:
** Dermata Therapeutics DRMA.O, up 115.3%
** NuZee NUZE.O, up 105.8%
** Pieris Pharmaceuticals PIRS.O, up 72.9%

The top two Nasdaq percentage losers premarket .PRPL.O:
** Vintage Wine Estates VWE.O, down 35.5%
** Conn's CONN.O, down 31%


** Alphabet GOOGL.O: down 3.6% premarket
BUZZ - Down; Q2 revenue and profit beat expectations nL4N3JG0PF


** Visa V.N: down 3.3% premarket
BUZZ - Falls after Q3 revenue miss nL4N3JG0M7


** Rivian Automotive RIVN.O: down 3.7% premarket
BUZZ - Drops as co to face trial in Tesla trade secrets theft case nL4N3JG0LK


** Estee Lauder Companies EL.N: up 1.0% premarket
BUZZ - Gains after RBC upgrades to 'outperform' on steady profit growth nL4N3JG0PO


** Enphase Energy ENPH.O: up 3.6% premarket
BUZZ - Gains after US sales grow nL4N3JG0SJ


** Verastem VSTM.O: down 24.2% premarket
BUZZ - Sinks on $55 mln stock-and-warrants offering nL1N3JG0EL


** Boston Scientific BSX.N: up 1.0% premarket
BUZZ - Up after lifting 2024 profit forecast nL4N3JG0UU


** AT&T T.N: up 2.6% premarket
BUZZ - Rises as Q2 subscriber additions beat estimates nL4N3JG0VO


** GE Vernova GEV.N: up 0.5% premarket
BUZZ - Gains after 2024 revenue forecast nL4N3JG0WV


(Compiled by Rajarshi Roy and Anuja Bharat Mistry in Bengaluru)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.